Savara Inc. Share Price

Savara Inc. Share Price

NASDAQ: SVRA | Small Cap
$4.96
-$0.06 (-1.2%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Savara Inc. Stock Performance

Open
$5.04
Prev. Close
$5.02
Circuit Range
N/A
Day Range
$4.92 - $5.13
Year Range
$3.87 - $7.00
Volume
1,38,354
Average Traded
$5.00

Savara Inc. Share Price Today

As of 30 October 2026, Savara Inc.'s share price is $4.96. The stock opened at $5.04, compared to its previous close of $5.02. During today's trading session, Savara Inc.'s share price traded between $4.92 and $5.13, with an average price of $5.03. Over the past 52 weeks, the stock has recorded a high of $7.00 and a low of $3.87. In terms of performance, Savara Inc.'s share price has declined by 5.16% over the last six months and is up 19.23% on a year-on-year basis.

Savara Inc. Share Price Chart

Line chart of the Savara Inc. price trend over the selected period. The price fell overall, ranging from 4.92 to 5.13, ending at 4.96.
$4.92$5.13
L
Show Current Price
H

Savara Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.10B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.68
Revenue (TTM)
$0.00
Return On Equity (TTM)
-96.97%
Profit Margin
N/A
Debt to Equity
0.21
Quarterly Earnings Growth YoY
-36.10%

Savara Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$29.56-$32.24-$37.28-$40.23
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-9.07%-15.63%-7.91%

Savara Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$38.15-$54.70-$95.88-$118.84
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-43.38%-75.28%-23.95%

About Savara Inc.

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

Savara Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$5.14
$4.96
-3.97%
Sep 2026
$5.33
$5.17
-5.91%
Aug 2026
$5.40
$5.50
+0.73%
Jul 2026
$6.13
$5.46
-11.80%
Jun 2026
$5.13
$6.18
+18.94%
May 2026
$5.20
$5.20
-0.57%
Apr 2026
$5.51
$5.23
-4.30%
Mar 2026
$6.00
$5.46
-9.22%
Feb 2026
$5.34
$6.02
+11.58%
Jan 2026
$5.97
$5.39
-10.46%
Dec 2025
$5.93
$6.03
-4.06%
Nov 2025
$4.16
$6.28
+50.96%

SVRA Share Price FAQs